**Core Concept**
Aspirin-sensitive asthma, also known as aspirin-exacerbated respiratory disease (AERD), is a complex condition characterized by chronic rhinosinusitis, asthma, and sensitivity to aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs). The underlying pathophysiology involves an imbalance in arachidonic acid metabolism, leading to the production of cysteinyl leukotrienes and other inflammatory mediators.

**Why the Correct Answer is Right**
Aspirin-sensitive asthma is associated with the presence of a specific genotype of the aspirin-intolerant asthma gene (AIA), which affects the expression of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2). This leads to an overproduction of cysteinyl leukotrienes through the 5-lipoxygenase pathway, resulting in chronic inflammation and symptoms. The condition is also characterized by the presence of nasal polyps and eosinophilia.

**Why Each Wrong Option is Incorrect**
**Option A:** While it is true that aspirin-sensitive asthma is associated with chronic rhinosinusitis, this statement is too general and does not specifically address the exception being asked.
**Option B:** This option is incorrect because aspirin-sensitive asthma is not simply a matter of genetic predisposition, but rather a complex interplay between genetic and environmental factors.
**Option C:** Aspirin-sensitive asthma is indeed characterized by an increased sensitivity to NSAIDs, but this statement does not address the specific exception being asked.
**Option D:** This option is incorrect because aspirin-sensitive asthma is actually associated with an overproduction of cysteinyl leukotrienes, not a deficiency.

**Clinical Pearl / High-Yield Fact**
Aspirin-sensitive asthma is a classic example of a condition that can be triggered by a seemingly innocuous medication, highlighting the importance of a thorough medical history and pharmacogenetic testing in managing patients with chronic respiratory disease.

**Correct Answer: D. Aspirin-sensitive asthma is associated with an overproduction of cysteinyl leukotrienes, not a deficiency.**